Micro-Sphere partnership to further support the commercial needs of its customers
Customers will receive comprehensive support particularly at the critical phases of industrial scale-up, technology transfer and process validation.
Switzerland-based CDMO Micro-Sphere has announced its partnership with PTM Consulting, a leading provider of risk management and process optimisation solutions for the life sciences industry.
The two companies will join forces to offer customers comprehensive support across the entire drug product development and manufacturing cycle, particularly at the critical phases of industrial scale-up, technology transfer and process validation.
The partnership is part of Micro-Sphere’s drive to increase its service offer to support the commercial needs of its customers.
Micro-Sphere’s expertise in the set-up and optimisation of processes for spray-drying, mixing and capsule filling will be complemented by PTM’s knowledge of quality by design (QbD) and risk management principles, tools and statistics.
The collaboration announcement comes at a pivotal time for Micro-Sphere, which recently appointed a new CEO, Michael Grassberger, the company’s former head of business development.
In his new leadership role, he hopes to spearhead the growth of the CDMO’s commercial operations and see Micro-Sphere become the leading service provider for inhalable powder production through spray-drying and capsule filling.
Grassberger said: “The application of PTM methodology to Micro-Sphere’s processes will facilitate successful technology transfers, ensuring customers meet their desired quality target while minimising costs, time and wastage.
“With Micro-Sphere’s reputation already well-established for early-stage clinical supply, we look to make our mark in the commercial arena so we can fully support our customers for the entire drug development and manufacturing cycle. The collaboration with PTM is central to this vision.
“PTM’s risk-based project approach, deep regulatory knowledge and state-of-the-art statistical tools will strengthen our management of complex projects for our customers and supplement the existing skills and expertise on our team.”
The company also recently successfully completed its bi-annual Swissmedic inspection of its facility near Lugano, resulting in the renewal of its GMP approved status.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance